640
Participants
Start Date
September 30, 2007
Primary Completion Date
April 30, 2009
Study Completion Date
September 30, 2009
Enbrel 50 mg Prefilled Syringe
Enbrel 50 mg subcutaneously once weekly for 12 Weeks using Prefilled Syringe
Enbrel 50 mg Autoinjector
Enbrel 50 mg subcutaneously once weekly for 12 Weeks using Autoinjector
Torino
Berlin
Stockholm
Marseille
Berlin
Alessandria
Vimercate
Cinisello Balsamo
Milan
Como
Zeven
Brest
S. Dona Di Piave
Hanover
Hanover
Toulouse
Nienburg
Montpellier
Montpellier
Padua
Göttingen
Verona
Grenoble
Bologna
Düsseldorf
Parma
Ferrara
Orléans
Essen
Cahors
Osnabrück
Cologne
Reims
Massa
Vandœuvre-lès-Nancy
Lille
Torrette Di Ancona
Frankfurt am Main
Fano
Bad Nauheim
Hofheim/Taunus
Coppito
Lyon
Pierre-Bénite
Foggia
S. Pietro Vernotico
Tübingen
Västerås
San Cesario di Lecce
Paris
Paris
Uppsala
Rouen
Villingen-Schwenningen
Niort
Amiens
Napoli
Napoli
München
Oberammergau
Ariano Irpino
Avignon
Reggio Calabria
Palermo
Erlangen
Erlangen
Corbeilles-Essonnes
Boulogne-Billancourt
Bad Abbach
Aulnay-sous-Bois
Würzburg
Frederiksberg
Hjørring
Holbæk
Silkeborg
Helsinki
Hyvinkää
Joensuu
Lohja
Pirna
Leipzig
Cagliari
Rieti
Roma
Roma
Terni
Arnhem
Eindhoven
Rotterdam
Gjettum
Harstad
Kristiansand
Lillehammer
Skien
Trondheim
Tønsberg
Danderyd
Malmo
Sundsvall
Vasterås
Ashford
Basingstoke
Cambridge
Chertsey
London
London
Manchester
Portsmouth
Southampton
Stoke-on-Trent
Truro
Westcliff-on-Sea
Wigan
Lead Sponsor
Pfizer
INDUSTRY